21-aminosteroid

Olefins are also the products of hydroboratlon of enamines, followed by treatment of the organoborane products with hot acid (543,544). The reduction of enamines with sodium borohydride and acetic acid (545) and the selective reduction of dienamines with sodium borohydride to give homo-allylic tertiary amines (138-140,225,546,547), has been applied to the synthesis of conessine (548) and other aminosteroid analogs (545,549-552). Further examples of the reduction of imonium salts by sodium borohydride can be found in the reduction of Bischler-Napieralski products, and other cyclic imonium salts (102). 

The rate of non-lgE-mediated immediate hypersensitivity reactions usually varies between 20 and 50% [1-7, 9], They are assumed to result from direct non-specific mast cell and basophil activation, which causes direct histamine release [19], Histamine release is predominantly found with the use of the benzylisoquinoUnes d-tubocurarine, atracurium and mivacurium, and the aminosteroid rapacuronium. Severe bronchospasm related to rapacuronium administration has been reported in children and adults. It might be related to the higher affinity of rapacuronium for M2 versus M3 muscarinic receptors [20]. Rapacuronium has been withdrawn from the market in the USA. 

In studies in Alzheimer s brain, in vitro induction of lipid peroxidation by iron is more intense than in control cortical samples (Andorn et al., 1990 Subbarao et nL, 1990 McIntosh et al., 1991). The 21-aminosteroid U-74500A has been shown to effectively inhibit iron-induced lipid peroxidation in Alzheimer s brain samples (Subbarao et al., 1990). 

Hall, E.D., Pazara, K.E. and Braughler, M.J. (1988). 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 19, 997-1002. 

A family of 3-aminosteroids reportedly inhibit lipid peroxidation while acting as anti-inflammatories. These activities were attributed to the combination of the steroid and the amine as neither component was, by itself, efiective (Spyriounis et /., 1993). In this sense, they resemble the 21-aminosteroid lazaroids. These 3-aminosteroids most probably inhibit lipid peroxidation through a physicochemical mechanism. 

Braughler, M.J., Hall, E.D., Jacobsen, E.J., McCall, J.M. and Means, E.D. (1989). The 21-aminosteroids potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14, 143-152. 

Richards, J.M., Griffin, KL. and Fidler, S.F. (1992). Hyperoxic lung injury in rats effect of the 21-aminosteroid U-74389F. Inflammation Research Association Meeting, Sixth International Conference, White Haven, PA, September 20-24. 

Spyriounis, D.M., Tani, E., Rekka, E., Demopoulos, V.J. and Kourounakis, P.N. (1993). Novel AT-substituted 3-aminosteroids which exhibit anti-inflammatory properties and influence free radical processes. Eur. J. Med. Chem. 28, 521-525. 

R.H. Fabian, D.S. deWitt, and T.A. Kent, The 21-aminosteroid U-74389G reduces cerebral superoxide anion concentration following fluid percussion injury of the brain. J. Neurotroma. 15, 433 140 (1998). 

We have described a method with high stereoselectivity which will be useful in the synthesis of squalamine analogs.It is promising in synthetic applications and will prove significant in the preparation of 3a-aminosteroids. These results are summarized in Table 4.4. 

Figure 6.1 Chemical structures of currently used aminosteroid relaxants.

About a third of an administered dose of rocuronium is excreted in the urine, the rest being taken up by the liver and excreted unchanged in the bile. Its elimination half-life is just under 100 minutes (Table 6.4). Unlike other aminosteroid relaxants, only very small amounts of the metabolite 17-desacetyl rocuronium have been found in plasma. The clearance of rocuronium is reduced in patients with significant renal and hepatic disease, with a possible prolongation of effect. The same mechanisms are responsible for prolongation of the block in the elderly. 

Marion D. W. and White M. J. (1996) Treatment of experimental brain injury with moderate hypothermia and 21-aminosteroids. J. Neurotrauma 13, 139-147. 

Subsequently, it was found that the substitution of a complex amine on the non-glucocorticoid steroid nucleus in place of the 21-hydroxyl functionality results in a dramatic enhancement of the lipid antioxidant activity. Many of these 21-aminosteroid compounds effectively inhibit iron-catalyzed lipid peroxidation in rat-brain tissue homogenates under assay conditions where the glucocorticoid steroid methylprednisolone and the non-glucocorticoid analog U-72099E are completely ineffective [20,21]. Of these, U-74006F (tirilazad mesylate Fig. 2) has shown excellent activity in experimental models of spinal-cord and brain injury. 

Microinjection of ferrous iron (i.e. ferrous chloride) has also been shown to produce focal edema in rat brain, the degree of which is correlated with tissue levels of the lipid-peroxidation product malonyldialdehyde. Pretreatment with vitamin E (600 mg/kg intramuscularly once daily for 5 days) together with selenium (5 ppm in the drinking water) reduced the iron-induced edema and lipid peroxidation [54]. Similarly, the 21-aminosteroid U-74006F can also reduce iron-induced opening of the blood-brain barrier [53],... 

More recently, the cerebral antioxidant activity of the 21-aminosteroid U-74006F has been enhanced by replacing the steroid functionality, which possesses only weak antioxidant activity without the complex amino substitution, with a more potent and effective antioxidant. A series of compounds has been synthesized in which the steroid of U-74006F has been replaced by the antioxidant ring structure (i.e. chromanol) of a-tocopherol (vitamin E). One of these compounds, U-78517F (Fig. 2) has been demonstrated to have predictably more potent effects with regard to inhibition of lipid peroxidation in vitro and enhancement of early neurological recovery of head-injured mice [62]. 

Braughler, J.M., Pregenzer, J.F., Chase, R.L., McCall, J.M. and Jacobsen, E.J. (1987) Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation, J. Biol. Chem. 262, 10438-10440. 

Monyer, H., Hartley, D.M. and Choi, D.W. (1990) 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures, Neuron 5, 121-126. 

---